220 related articles for article (PubMed ID: 32452140)
1. Traumatic brain injury.
Bailes JE; Borlongan CV
CNS Neurosci Ther; 2020 Jun; 26(6):593-594. PubMed ID: 32452140
[No Abstract] [Full Text] [Related]
2. Preparing regenerative therapies for clinical application: proposals for responsible translation.
Shapiro SA; Smith CG; Arthurs JR; Master Z
Regen Med; 2019 Feb; 14(2):77-84. PubMed ID: 30651044
[No Abstract] [Full Text] [Related]
3. Regenerative medicine: future impact on clinical therapies and society.
Kargul J; Laurent GJ; Irminger-Finger I
Int J Biochem Cell Biol; 2014 Nov; 56():1. PubMed ID: 25461768
[No Abstract] [Full Text] [Related]
4. Youthful prospects for human stem-cell therapy. In another few decades, revised attitudes toward stem cells could lead to disease prevention and life extension.
Rosenthal N
EMBO Rep; 2005 Jul; 6 Spec No(Suppl 1):S30-4. PubMed ID: 15995658
[TBL] [Abstract][Full Text] [Related]
5. The advancement of human pluripotent stem cell-derived therapies into the clinic.
Thies RS; Murry CE
Development; 2015 Sep; 142(18):3077-84. PubMed ID: 26395136
[TBL] [Abstract][Full Text] [Related]
6. [Current status and perspective on regenerative medicine for spinal cord injury using iPS cell].
Nakamura M; Toyama Y; Okano H
Rinsho Shinkeigaku; 2013; 53(11):1013-5. PubMed ID: 24291863
[TBL] [Abstract][Full Text] [Related]
7. Cell-based therapies for the preterm infant.
Zhu D; Wallace EM; Lim R
Cytotherapy; 2014 Dec; 16(12):1614-28. PubMed ID: 25154811
[TBL] [Abstract][Full Text] [Related]
8. Stem cell-based treatment of kidney diseases.
Pan B; Fan G
Exp Biol Med (Maywood); 2020 May; 245(10):902-910. PubMed ID: 32281411
[TBL] [Abstract][Full Text] [Related]
9. Regulating cell-based regenerative medicine: the challenges ahead.
Ali RR; Hollander AP; Kemp P; Webster A; Wilkins MR
Regen Med; 2014 Jan; 9(1):81-7. PubMed ID: 24351008
[TBL] [Abstract][Full Text] [Related]
10. Regenerative medicine for spinal cord injury: focus on stem cells and biomaterials.
Papa S; Pizzetti F; Perale G; Veglianese P; Rossi F
Expert Opin Biol Ther; 2020 Oct; 20(10):1203-1213. PubMed ID: 32421405
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic potential of human adipose-derived stem cells in neurological disorders.
Chang KA; Lee JH; Suh YH
J Pharmacol Sci; 2014; 126(4):293-301. PubMed ID: 25409785
[TBL] [Abstract][Full Text] [Related]
12. [Regenerative therapy for post-stroke patients].
Yamashita T; Abe K
Nihon Rinsho; 2016 Apr; 74(4):661-5. PubMed ID: 27333756
[TBL] [Abstract][Full Text] [Related]
13. Computational Strategies for Niche-Dependent Cell Conversion to Assist Stem Cell Therapy.
Del Sol A; Okawa S; Ravichandran S
Trends Biotechnol; 2019 Jul; 37(7):687-696. PubMed ID: 30782480
[TBL] [Abstract][Full Text] [Related]
14. Concise Review: Cell Therapies for Stroke and Traumatic Brain Injury: Targeting Microglia.
Savitz SI; Cox CS
Stem Cells; 2016 Mar; 34(3):537-42. PubMed ID: 26844424
[TBL] [Abstract][Full Text] [Related]
15. Emerging Translation of Regenerative Therapies.
Allickson JG
Clin Pharmacol Ther; 2017 Jan; 101(1):28-30. PubMed ID: 27806427
[TBL] [Abstract][Full Text] [Related]
16. Proceedings of the signature series event of the international society for cellular therapy: "Advancements in cellular therapies and regenerative medicine in digestive diseases," London, United Kingdom, May 3, 2017.
Ciccocioppo R; Dos Santos CC; Baumgart DC; Cangemi GC; Cardinale V; Ciacci C; De Coppi P; Haldar D; Klersy C; Nostro MC; Ott M; Piemonti L; Tomei AA; Uygun B; Vetrano S; Orlando G
Cytotherapy; 2018 Mar; 20(3):461-476. PubMed ID: 29398624
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stem cell therapy for the treatment of traumatic brain injury: progress and prospects.
Das M; Mayilsamy K; Mohapatra SS; Mohapatra S
Rev Neurosci; 2019 Nov; 30(8):839-855. PubMed ID: 31203262
[TBL] [Abstract][Full Text] [Related]
18. [Development of Cellular and Tissue-based Products for Retinal Regenerative Medicine].
Osakada F
Yakugaku Zasshi; 2017; 137(1):23-29. PubMed ID: 28049891
[TBL] [Abstract][Full Text] [Related]
19. CellCAN: a unique enabler of regenerative medicine and cell therapy in Canada.
Roy DC; Alarco AM; Isasi R
Stem Cells Dev; 2014 Dec; 23 Suppl 1():24-8. PubMed ID: 25457957
[TBL] [Abstract][Full Text] [Related]
20. Component therapy to cellular therapy and beyond- a Darwinian approach to transfusion medicine.
Snyder EL
Transfusion; 2008 Sep; 48(9):2000-7. PubMed ID: 18694467
[No Abstract] [Full Text] [Related]
[Next] [New Search]
